image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Lords Group Trading - Acquisitive builders merchant aims to more than double EBITDA by 2024

November 2021

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • LORD
  • Price:
  • 127.5p
When I first started writing this newsletter the unwritten rule when it came to new issues was that the company should have a three year record of profit growth but these days most IPOs seem to be loss making yet still often command £1 billion + valuations. However, Lords Group Trading, a specialist distributor of building, plumbing, heating and DIY products, is my kind of old school new issue, having increased turnover from £246m to £288m between FY’18-’20; in the latest H1 ’21 it jumped 44% to £179m. In turn, EBITDA profit grew from £10.1m in FY’18 to £11.4m in FY’20 and in H1 ’21 increased a further 62% to £10.5m. Not surprisingly, the shares have performed well, rising from the placing price of 95p but the really interesting thing is ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author